Buprenorphine Hydrochloride marketed by Actavis Pharma, Inc. under NDC Code 0228-3156-03
NDC Code(s) : 0228-3156-03, 0228-3153-03
Packager : Actavis Pharma, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : CIII
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
BuprenorphineBuprenorphine TABLET |
|
|
|
|
|
|
BuprenorphineBuprenorphine TABLET |
|
|
|
|
|
|
PRINCIPAL DISPLAY PANEL
NDC 0228-3156-03
Buprenorphine Sublingual Tablets 2 mg* CIII
PHARMACIST: Dispense the accompanying Medication Guide to each patient.
Children who accidentally take buprenorphine will need emergency medical care. Keep out of the reach of children.
Rx only
30 Tablets
PRINCIPAL DISPLAY PANEL
NDC 0228-3153-03
Buprenorphine Sublingual Tablets 8 mg* CIII
PHARMACIST: Dispense the accompanying Medication Guide to each patient.
Children who accidentally take buprenorphine will need emergency medical care. Keep out of the reach of children.
Rx only
30 Tablets
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.